A narrative exploration of psilocybin’s potential in mental health
Frontiers in Psychiatry – October 30, 2024
Source: OpenAlex
Summary
Psilocybin, a potent hallucinogen, is demonstrating high therapeutic potential in psychiatry. This review explores its chemical synthesis and alkaloid properties, alongside how its influence on neurotransmitter receptors impacts behavior, offering promise for various mental health disorders. Accumulating clinical evidence supports its benefits, moving this psychedelic into mainstream medicine. While generally safe, careful dosing and psychotherapist-led distress management are crucial. This burgeoning field of Psychedelics and Drug Studies aims to integrate psilocybin into psychology and psychiatric treatments, paving the way for its wider acceptance.
Abstract
Psilocybin, a psychoactive substance, has recently garnered attention for its high therapeutic potential in psychiatry. In this study, we investigated the multifaceted aspects of psilocybin, highlighting its chemical properties, mechanisms of action, and burgeoning role in psychiatric treatment. Furthermore, we examined the clinical applications and potential therapeutic benefits of psilocybin in the treatment of various mental health disorders, supported by accumulating clinical evidence. This review aims to deepen our understanding of the clinical impact of psilocybin, elucidate its therapeutic value, and propose directions for future research, thereby paving the way for its integration into mainstream psychiatric treatments. Psilocybin has been shown to be safe in clinical trials with manageable side effects. However, additional safety measures are required after this discussion, including dosing protocols, patient monitoring, and distress management strategies.